Brief: Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC In Germany

Halozyme Therapeutics

04/12/2025 18:30

Dec 4 (Reuters) - Halozyme Therapeutics Inc HALO.O:

HALOZYME WINS PRELIMINARY INJUNCTION AGAINST MERCK'S KEYTRUDA SC IN GERMANY

HALOZYME THERAPEUTICS: AS CONSEQUENCE OF INJUNCTION MERCK'S LAUNCH ACTIVITIES FOR KEYTRUDA SC IN GERMANY WITHIN SCOPE OF ORDER MUST BE HALTED

HALOZYME THERAPEUTICS: OUTCOME OF THE INFRINGEMENT LAWSUIT AGAINST MERCK WILL NOT IMPACT ENHANZE

HALOZYME THERAPEUTICS INC - IV VERSION OF KEYTRUDA REMAINS AVAILABLE TO PATIENTS

Source text: ID:nPn7rlVd5a

Further company coverage: HALO.O

 ((Reuters.Briefs@thomsonreuters.com;))